MedPath

Early Feeds in Gastroschisis

Not Applicable
Recruiting
Conditions
Gastroschisis
Registration Number
NCT06878950
Lead Sponsor
University of California, Davis
Brief Summary

This study aims to evaluate the feasibility of initiating early feeds in neonates with gastroschisis, a condition where infants are born with their intestines outside the body.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Neonates with presumed simple gastroschisis
  • Born at ≥ 34 weeks' gestation
  • Hemodynamically stable
  • Consented within 48 hours after abdominal closure
  • Mothers who are ≥16 years old
  • Mothers who speak English or Spanish
Exclusion Criteria
  • Neonates with evidence of complex gastroschisis at time of closure (any ischemic bowel, intestinal perforation, or obvious atresia with mesenteric defect)
  • Presence of any major congenital anomalies
  • Neonates who are receiving ionotropic medications
  • Neonates who are wards of the state
  • Neonates whose care is considered to be futile or those undergoing re-direction of care
  • Neonates participating in another interventional trial
  • Any patient deemed unfit for participation by study investigator(s)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Feasibility of Enrollment in Early Feeding Study CohortFrom prenatal period within the first 24 hours of abdominal closure

Proportion of eligible neonates with gastroschisis whose parents/guardians consent to enrollment in the study.

Secondary Outcome Measures
NameTimeMethod
Feasibility of Protocol AdherenceFrom abdominal closure to 48 hours after closure.

Proportion of enrolled neonates who are initiated on introductory feeds within 48 hours of abdominal closure.

Fidelity to ProtocolFrom abdominal closure through discharge from the hospital, average of 90 days

Proportion of enrolled infants with gastroschisis who adhere to the remainder of the protocol without major deviations. Feasibility will be assessed using protocol adherence tracking forms completed by study team.

Protocol Withdrawal RateFrom time of enrollment (prenatal) to hospital discharge, an average of 90 days

Proportion of enrolled infants who withdraw from the study

Trial Locations

Locations (2)

UC Davis Children's Hospital

🇺🇸

Sacramento, California, United States

University of California Los Angeles

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath